Catalyst Wire Dossier Catalyst Wire Dossier

PfSPZ-LARC2 vaccine

PfSPZ-LARC2 · Sanaria Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PfSPZ-LARC2 vaccine, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults [Phase 1]

See pricing